Company Name CardioKinetix
Mailing Address 925 Hamilton Avenue Menlo Park, CA 94025
Company Description CardioKinetix, Inc. is developing new technology for treating Congestive Heart Failure (CHF). This is a catheter-based intervention implanted into the heart. CHF results from damage to the heart from several causes, which affects nearly five million people in the U.S.
Proceeds Purposes This financing provides CardioKinetix the capital necessary to substantially progress the development of our PARACHUTE™ device, including conducting clinical studies to further support the initial commercialization of Parachute in Europe and a PMA submission to FDA.